Trial Profile
A Randomized Pilot Trial of a Steroid-Free Immunosuppressant Regimen in Pediatric Liver Transplantation
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Daclizumab (Primary) ; Hydrocortisone (Primary) ; Methylprednisolone (Primary) ; Prednisolone (Primary) ; Corticosteroids; Immunosuppressants
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms SFPT-OL
- 21 Mar 2015 United Kingdom Clinical Research Network reports accrual to date changed from 66% to 70%.
- 22 Oct 2013 Status changed from recruiting to discontinued as reported by ISRCTN: Current Controlled Trials.
- 07 Jul 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2007-004822-26)